Q2 and FY consensus estimates

Estimates for Q2 and FY 2020/21 based on median.

      Q2 2020/21            FY 2020/21  
DKKm   Low Consensus High   Low Consensus High
                 
Revenue  

958

1,016  1,097   4,014 4,233 4,366
Gross profit  

585

650 699  

2,526

2,704 2,811
Gross margin  

60.6%

63.0% 65.3%  

62.6%

63.9% 65.5%
EBIT before special items  

79

111 149   479 509 583
EBIT margin before special items  

8.2%

11.0% 13.6%   11.6% 12.1% 13.5%
Net profit  

44

75 113   278 349 438
Net profit margin  

4.5%

7.5% 10.6%   6.8% 8.2% 10.0%
                 
Endoscopes sold (units)   300,000 336,475 375,000  

1,371,320

1,417,895 1,488,798
Organic growth   1.8% 8.4% 12.4%  

16.5%

20.3% 24.7%

4 May 2021, based on estimates from 11 analysts.

keyboard_arrow_up